23andMe Holding Co. (NASDAQ:ME) Insider Sells $18,889.99 in Stock

23andMe Holding Co. (NASDAQ:ME) insider Kathy L. Hibbs sold 38,551 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $0.49, for a total value of $18,889.99. Following the sale, the insider now directly owns 1,252,315 shares of the company’s stock, valued at approximately $613,634.35. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

23andMe Stock Up 2.3 %

Shares of NASDAQ:ME opened at $0.50 on Wednesday. 23andMe Holding Co. has a 12-month low of $0.35 and a 12-month high of $2.21. The business has a 50 day moving average of $0.49 and a 200-day moving average of $0.69. The stock has a market cap of $240.30 million, a PE ratio of -0.45 and a beta of 1.24.

23andMe (NASDAQ:ME) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share (EPS) for the quarter. The firm had revenue of $44.75 million during the quarter, compared to the consensus estimate of $56.30 million. 23andMe had a negative net margin of 210.48% and a negative return on equity of 52.99%.

Analysts Set New Price Targets

Separately, Citigroup dropped their price objective on shares of 23andMe from $0.85 to $0.47 and set a “neutral” rating on the stock in a research report on Tuesday, April 16th.

Institutional Investors Weigh In On 23andMe

Hedge funds and other institutional investors have recently modified their holdings of the company. China Universal Asset Management Co. Ltd. grew its stake in shares of 23andMe by 361.0% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 36,049 shares of the company’s stock valued at $33,000 after acquiring an additional 28,229 shares in the last quarter. Raymond James & Associates boosted its holdings in 23andMe by 113.5% in the 3rd quarter. Raymond James & Associates now owns 36,173 shares of the company’s stock valued at $35,000 after purchasing an additional 19,233 shares during the period. Vanguard Personalized Indexing Management LLC acquired a new position in shares of 23andMe during the 3rd quarter worth approximately $37,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of 23andMe by 58.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 61,167 shares of the company’s stock worth $56,000 after purchasing an additional 22,460 shares during the period. Finally, SG Americas Securities LLC acquired a new stake in shares of 23andMe in the third quarter valued at approximately $130,000. Institutional investors and hedge funds own 36.10% of the company’s stock.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.